Company filings on SEC EDGAR · Form 8-K (company current report)
Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. filed a Form 8-K (current report) with the U.S. Securities and Exchange Commission on April 16, 2026. A Form 8-K discloses a material corporate event; it is a company filing, not an enforcement action.
Read the official source on sec.gov →
- Issued by
- Aspire Biopharma Holdings, Inc., filed with the U.S. Securities and Exchange Commission
- Document type
- Form 8-K (company current report)
- Date
- First recorded by CourtPulse
- · all records that day
- Company
- Aspire Biopharma Holdings, Inc. · SEC CIK 1847345
CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.